What other stocks do shareholders of Invion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invion investors own include Denbury Resources (DNR) , Walt Disney (DIS) , Carlisle Companies (CSL) , Cyclone Metals Limited (CFE.AX) (CFE) , Camtek (CAMT) , Boston Properties (BXP) , BioSpecifics Technologies (BSTC) , BJ's Restaurants (BJRI) , Banco Bradesco (BBD) and Aggreko (AGK) .

ASX:IVX

Invion (IVX) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free IVX Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 471,000 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Invion alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Invion Stock (ASX:IVX)

Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

IVX Stock News Headlines

April 16, 2024 | morningstar.com

InVision Software AG IVX

April 11, 2024 | theguardian.com

First Thing: Date set for Israel’s invasion of Rafah, Netanyahu says

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

April 11, 2024 | mirror.co.uk

Israel has date picked out for 'eliminating terrorist battalions' in Rafah ground invasion

April 9, 2024 | usatoday.com

Suspect charged with murder, home invasion in deadly Illinois stabbing and beating rampage

March 17, 2024 | theglobeandmail.com

Stocks in August are DROPPING – Here’s Why

March 15, 2024 | theglobeandmail.com

Gas Prices About to Skyrocket, Gas Economics 101

March 6, 2024 | bbc.co.uk

Watch: Tumbleweed invasion engulfs US streets

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 26, 2024 | msn.com

Doctor Who 1960s movies get price cut

December 14, 2023 | bbc.com

Ukraine invasion: False claims the war is a hoax go viral

November 29, 2023 | businessinsider.com

Russia was taken by surprise when it lost 76 passenger planes due to Ukraine invasion sanctions, minister says

November 29, 2023 | businessinsider.com

Russia offered to end its invasion of Ukraine if it dumped plans to join NATO, but Kyiv feared a double cross, says negotiator

November 21, 2023 | nypost.com

Philly business owner and his family tied up in home invasion witnessed by 4-year-old daughter: video

November 19, 2023 | theguardian.com

Russia-Ukraine war at a glance: what we know on day 602 of the invasion

October 27, 2023 | mirror.co.uk

Palestinians trying to flee Israel Gaza invasion scream 'we didn't kill anyone'

October 27, 2023 | theglobeandmail.com

Meta Sparks a Sharp Sell-off in Tech Stocks

October 24, 2023 | usatoday.com

'Preparing to die': Palestinians flee as Gaza braces for Israeli ground invasion

October 23, 2023 | theglobeandmail.com

Markets Today: Global Stocks Slide as Bond Yields Climb

October 18, 2023 | mirror.co.uk

Britain faces invasion of 'super' bedbugs 'resistant to insecticides', expert warns

October 13, 2023 | theglobeandmail.com

Stocks End Mostly Lower on Geopolitical Risks in the Middle East

October 12, 2023 | theglobeandmail.com

Middle East War: 3 Top-Rated Defense Stocks for Your Portfolio

October 11, 2023 | theguardian.com

Russia-Ukraine war at a glance: what we know on day 591 of the invasion

September 24, 2023 | msn.com

ASX Health Stocks: Starpharma full steam ahead on VIRALEZE study, Dimerix to use QYTOVRA as brand name

August 23, 2023 | cbsnews.com

Man charged in Indiana County home invasion

July 20, 2023 | theguardian.com

Secret Invasion recap episode one – it’s true, the world has been invaded by reptilians disguised as humans!

July 1, 2023 | theglobeandmail.com

Sánchez visits Kyiv on the day Spain starts EU presidency to underline bloc's support for Ukraine

See More Headlines

Receive IVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: ASX:IVX
CUSIP: N/A
CIK: N/A
Web: www.inviongroup.com
Phone: 61 3 9081 6005
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,500,000.00
Net Margins: -34.15%
Pretax Margin: N/A
Return on Equity: -8.12%
Return on Assets: -5.16%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.19
Quick Ratio: 18.63

Sales & Book Value

Annual Sales: $4.39 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 15.00
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 6,420,000,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.20

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Thian Chew
Executive Chairman & CEO
Ms. Melanie Jaye Leydin B.Bus (Age 51)
C.A., Chief Financial Officer
Dr. Dean Naylor
Head of Intellectual Property Development
Ms. Claire Newstead-Sinclair C.A.
Company Secretary

Key Competitors

View All Competitors

Insiders

IVX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Invion own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Invion investors own include Denbury Resources (DNR), Walt Disney (DIS), Carlisle Companies (CSL), Cyclone Metals Limited (CFE.AX) (CFE), Camtek (CAMT), Boston Properties (BXP), BioSpecifics Technologies (BSTC), BJ's Restaurants (BJRI), Banco Bradesco (BBD) and Aggreko (AGK).

This page (ASX:IVX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial